Home Other Building Blocks Dicyandiamide

Dicyandiamide

CAS No.:
461-58-5
Catalog Number:
AG0037SC
Molecular Formula:
C2H4N4
Molecular Weight:
84.0800
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
98%
In Stock USA
United States
$13
- +
25g
98%
In Stock USA
United States
$19
- +
100g
98%
In Stock USA
United States
$50
- +
500g
98%
In Stock USA
United States
$108
- +
Product Description
Catalog Number:
AG0037SC
Chemical Name:
Dicyandiamide
CAS Number:
461-58-5
Molecular Formula:
C2H4N4
Molecular Weight:
84.0800
MDL Number:
MFCD00008066
IUPAC Name:
2-cyanoguanidine
InChI:
InChI=1S/C2H4N4/c3-1-6-2(4)5/h(H4,4,5,6)
InChI Key:
QGBSISYHAICWAH-UHFFFAOYSA-N
SMILES:
NC(=N)NC#N
EC Number:
207-312-8
UNII:
M9B1R0C16H
NSC Number:
2031
RTECS Number:
ME9950000
Properties
Complexity:
100  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
84.044g/mol
Formal Charge:
0
Heavy Atom Count:
6  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
84.082g/mol
Monoisotopic Mass:
84.044g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
88.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.2  
Literature
Title Journal
Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups. Bioorganic & medicinal chemistry letters 20121215
Design, synthesis and antibacterial activity of minor groove binders: the role of non-cationic tail groups. European journal of medicinal chemistry 20121001
Synthesis and biological evaluation of cyanoguanidine derivatives of loratadine. Bioorganic & medicinal chemistry letters 20121001
Poly[bis-(1-carbamoylguanidinium) [tri-μ-chlorido-dichloridobismuthate(III)]]. Acta crystallographica. Section E, Structure reports online 20120501
Alkoxy-1,3,5-triazapentadien(e/ato) copper(II) complexes: template formation and applications for the preparation of pyrimidines and as catalysts for oxidation of alcohols to carbonyl products. Chemistry (Weinheim an der Bergstrasse, Germany) 20120116
A liquid chromatography-tandem mass spectrometry method for the detection of economically motivated adulteration in protein-containing foods. Journal of chromatography. A 20120113
Tris(2-carbamoylguanidinium) hydrogen fluoro-phospho-nate fluoro-phospho-nate monohydrate. Acta crystallographica. Section E, Structure reports online 20120101
[Effects of nitrification inhibitors DCD and DMPP on cinnamon soil' s gross nitrogen mineralization and nitrification rates]. Ying yong sheng tai xue bao = The journal of applied ecology 20120101
Synthesis and histamine H(3) and H(4) receptor activity of conformationally restricted cyanoguanidines related to UR-PI376. Archiv der Pharmazie 20111201
Aging impairs vasodilatory responses in rats. Korean journal of anesthesiology 20111201
2-(1,3-Benzothia-zol-2-yl)guanidinium chloride. Acta crystallographica. Section E, Structure reports online 20111101
[Mitigation of nitrous oxide emissions in vegetable system by treating soil with dicyandiamide, a nitrification inhibitor]. Huan jing ke xue= Huanjing kexue 20111101
Direct synthesis of nanoporous carbon nitride fibers using Al-based porous coordination polymers (Al-PCPs). Chemical communications (Cambridge, England) 20110728
Thiourea isosteres as anion receptors and transmembrane transporters. Chemical communications (Cambridge, England) 20110721
Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer. Investigational new drugs 20110401
Complexes of copper(II) with 3-(ortho-substituted phenylhydrazo)pentane-2,4-diones: syntheses, properties and catalytic activity for cyclohexane oxidation. Dalton transactions (Cambridge, England : 2003) 20110328
Novel chelating resin with cyanoguanidine group: useful recyclable materials for Hg(II) removal in aqueous environment. Journal of hazardous materials 20110130
The resistance of the yeast Saccharomyces cerevisiae to the biocide polyhexamethylene biguanide: involvement of cell wall integrity pathway and emerging role for YAP1. BMC molecular biology 20110101
Histamine H4 receptor agonists. Bioorganic & medicinal chemistry letters 20101215
Effect of cattle slurry pre-treatment by separation and addition of nitrification inhibitors on gaseous emissions and N dynamics: a laboratory study. Chemosphere 20100401
Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index. International journal of nanomedicine 20100101
Partial purification and characterization of the mode of action of enterocin S37: a bacteriocin produced by Enterococcus faecalis S37 isolated from poultry feces. Journal of environmental and public health 20100101
Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase. BMC cancer 20100101
Determination of impurities in medical products containing metformin hydrochloride. Acta poloniae pharmaceutica 20100101
Bis(1-carbamimidoyl-2-ethyl-isourea)copper(II) dinitrate. Acta crystallographica. Section E, Structure reports online 20091101
Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists. Journal of medicinal chemistry 20091022
Development and validation of an analytical method for metformin hydrochloride and its related compound (1-cyanoguanidine) in tablet formulations by HPLC-UV. Talanta 20091015
Bis(1-carbamimidoyl-2-ethyl-isourea)copper(II) bis-(perchlorate). Acta crystallographica. Section E, Structure reports online 20091001
Different routes for amination of platinum(II)-bound cyanoguanidine. Inorganic chemistry 20090921
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors. Bioorganic & medicinal chemistry letters 20090801
Modulatory action of potassium channel openers on field potential and histamine release from rat peritoneal mast cells. Canadian journal of physiology and pharmacology 20090801
Purinergic P2X(7) receptor antagonists: Chemistry and fundamentals of biological screening. Bioorganic & medicinal chemistry 20090715
Effect of timing of joint application of hydroquinone and dicyandiamide on nitrous oxide emission from irrigated lowland rice paddy field. Chemosphere 20090601
Bis[diamino-(ethoxy-carbonyl-amino)-methyl-ium] sulfate. Acta crystallographica. Section E, Structure reports online 20090401
Selective P2X(7) receptor antagonists for chronic inflammation and pain. Purinergic signalling 20090301
The use of microelectrode array (MEA) to study the protective effects of potassium channel openers on metabolically compromised HL-1 cardiomyocytes. Physiological measurement 20090201
Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments. Journal of translational medicine 20090101
Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drug. BMC research notes 20090101
Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists. Bioorganic & medicinal chemistry letters 20080715
Attenuation of N2O emission rates from agricultural soil at different dicyandiamide concentrations. Environmental monitoring and assessment 20080201
Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder. Journal of medicinal chemistry 20071129
Design, synthesis, and SAR study of a series of N-alkyl-N'-[2-(aryloxy)-5-nitrobenzenesulfonyl]ureas and -cyanoguanidine as selective antagonists of the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor. Journal of medicinal chemistry 20070809
Novel P2X7 receptor antagonists ease the pain. British journal of pharmacology 20070701
Overactive bladder treatments in early phase clinical trials. Expert opinion on investigational drugs 20070701
Molecular structure, bioavailability and bioactivity of [Cu(o-phen)2(cnge)](NO3)2.2H2O and [Cu(o-phen)(cnge)(H2O)(NO3)2] complexes. Journal of inorganic biochemistry 20070501
Biodegradability of end-groups of the biocide polyhexamethylene biguanide (PHMB) assessed using model compounds. Journal of industrial microbiology & biotechnology 20060801
[Effects of nitrification inhibitors on nitrate content in soil and pakchoi and on pakchoi yield]. Ying yong sheng tai xue bao = The journal of applied ecology 20060201
Structure-activity relationships of K(ATP) channel openers. Current topics in medicinal chemistry 20060101
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. British journal of cancer 20050822
[HPLC determination of metformin hydrochloride-related substances]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20050701
Effects of slow-release urea fertilizers on urease activity, microbial biomass, and nematode communities in an aquic brown soil. Science in China. Series C, Life sciences 20050501
Quantitative structure-activity relationship by CoMFA for cyclic urea and nonpeptide-cyclic cyanoguanidine derivatives on wild type and mutant HIV-1 protease. Journal of molecular modeling 20050301
Neuroprotective effect of KR-31378, a novel potassium channel activator, on spinal cord ischemic injury in rabbits. Journal of investigative surgery : the official journal of the Academy of Surgical Research 20050101
Antitumoural effects of the pyridyl cyanoguanidine CHS 828 on three different types of neuroendocrine tumours xenografted to nude mice. Neuroendocrinology 20050101
Effect of two amino acids in TM17 of Sulfonylurea receptor SUR1 on the binding of ATP-sensitive K+ channel modulators. Diabetes 20041201
Novel glycine transporter type-2 reuptake inhibitors. Part 2: beta- and gamma-amino acid derivatives. Bioorganic & medicinal chemistry 20040815
Arylcyanoguanidines as activators of Kir6.2/SUR1K ATP channels and inhibitors of insulin release. Journal of medicinal chemistry 20040603
Hypotonic stress increases efficacy of rilmakalim, but not pinacidil, to activate ATP-sensitive K(+) current in guinea pig ventricular myocytes. Journal of pharmacological sciences 20040601
Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828. Molecular cancer therapeutics 20040501
Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075. British journal of pharmacology 20040401
Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating properties. Journal of medicinal chemistry 20040129
Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder. Bioorganic & medicinal chemistry letters 20040119
Dihydropyridine neuropeptide Y Y1 receptor antagonists 2. bioisosteric urea replacements. Bioorganic & medicinal chemistry 20040115
Development and characterization of two human tumor sublines expressing high-grade resistance to the cyanoguanidine CHS 828. Anti-cancer drugs 20040101
Dicyandiamide and 3,4-dimethyl pyrazole phosphate decrease N2O emissions from grassland but dicyandiamide produces deleterious effects in clover. Journal of plant physiology 20031201
A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine. Journal of medicinal chemistry 20030703
Bis(cyanoguanidine)silver(I) nitrate-cyanoguanidine (1/1). Acta crystallographica. Section C, Crystal structure communications 20030601
Synthesis and biological activity of 3,3-diamino-sulfonylacrylonitriles as novel inhibitors of glucose induced insulin secretion from beta cells. Bioorganic & medicinal chemistry 20030320
A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors. European journal of medicinal chemistry 20030101
Activation of p53 protein in normal and in tumor cells by a novel anticancer agent CHS 828. Drugs under experimental and clinical research 20030101
The stereoenantiomers of a pinacidil analog open or close cloned ATP-sensitive K+ channels. The Journal of biological chemistry 20021025
The combination of the antitumoural pyridyl cyanoguanidine CHS 828 and etoposide in vitro--from cytotoxic synergy to complete inhibition of apoptosis. British journal of pharmacology 20021001
Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives. Journal of medicinal chemistry 20020926
Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: arginine substitution. Bioorganic & medicinal chemistry letters 20020902
Interactions between the new cytotoxic drug CHS 828 and amiloride and mitomycin C in a human tumour cell line and in tumour cells from patients. Chemotherapy 20020901
A Phase I study of CHS 828 in patients with solid tumor malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research 20020901
Emission of nitrous oxide from rice-wheat systems of Indo-Gangetic plains of India. Environmental monitoring and assessment 20020701
Hydrophobic similarity between molecules: a MST-based hydrophobic similarity index. Journal of computational chemistry 20020415
Modulation of pyridyl cyanoguanidine (CHS 828) induced cytotoxicity by 3-aminobenzamide in U-937 GTB cells. Biochemical pharmacology 20020415
Tricyclic cyanoguanidines: synthesis, site of action and insecticidal activity of a novel class of reversible acetylcholinesterase inhibitors. Bioorganic & medicinal chemistry 20020301
Synthesis of 5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidine-N-cyanoguanidine derivatives as inhibitors of ras farnesyl protein transferase. Bioorganic & medicinal chemistry letters 20020225
A novel anti-ischemic ATP-sensitive potassium channel (K(ATP)) opener without vasorelaxation: N-(6-aminobenzopyranyl)-N'-benzyl-N' '-cyanoguanidine analogue. Journal of medicinal chemistry 20011122
Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties. Bioorganic & medicinal chemistry letters 20010212
A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828. Anti-cancer drugs 20010101
A modified spray reagent for the detection of amino acids on thin layer chromatography plates. Amino acids 20010101
Occupational allergic contact dermatitis caused by 2,4,6-tris-(dimethylaminomethyl)phenol, and review of sensitizing epoxy resin hardeners. International journal of dermatology 19961201
Properties